CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $7.6 million in its fourth quarter.
On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 4 cents.
The kidney disease treatment developer posted revenue of $55.2 million in the period.
For the year, the company reported that its loss narrowed to $92.6 million, or 51 cents per share. Revenue was reported as $292.6 million.
The company’s shares closed at $1.03. A year ago, they were trading at $2.53.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
